M

Mega Lifesciences PCL
SET:MEGA

Watchlist Manager
Mega Lifesciences PCL
SET:MEGA
Watchlist
Price: 32.5 THB -0.76% Market Closed
Market Cap: 28.3B THB
Have any thoughts about
Mega Lifesciences PCL?
Write Note

Mega Lifesciences PCL
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Mega Lifesciences PCL
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
M
Mega Lifesciences PCL
SET:MEGA
Cash & Cash Equivalents
฿2.9B
CAGR 3-Years
21%
CAGR 5-Years
22%
CAGR 10-Years
9%
B
Bangkok Lab and Cosmetic PCL
SET:BLC
Cash & Cash Equivalents
฿90.5m
CAGR 3-Years
122%
CAGR 5-Years
124%
CAGR 10-Years
N/A
No Stocks Found

Mega Lifesciences PCL
Glance View

Market Cap
28.3B THB
Industry
Pharmaceuticals

Mega Lifesciences Public Co. Ltd. engages in the manufacture, market, sale, and distribution of pharmaceutical, nutraceutical products, and consumer goods. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2013-11-19. The firm's products include complimentary medicines, over-the-counter (OTC) medicines and prescription medicines to both domestic and international markets. The company distributes products under Maxxcare brand covering prescription pharmaceutical products, OTC drugs and other consumer products. The firm also offers nutritional products, prescription pharmaceutical products and OTC drugs under Mega We Care brand. In addition, the Company operates as an original equipment manufacturer (OEM) for various products including health supplements, pharmaceutical, herbal products, vitamins and minerals, among others.

MEGA Intrinsic Value
53.75 THB
Undervaluation 40%
Intrinsic Value
Price
M

See Also

What is Mega Lifesciences PCL's Cash & Cash Equivalents?
Cash & Cash Equivalents
2.9B THB

Based on the financial report for Sep 30, 2024, Mega Lifesciences PCL's Cash & Cash Equivalents amounts to 2.9B THB.

What is Mega Lifesciences PCL's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
9%

Over the last year, the Cash & Cash Equivalents growth was 38%. The average annual Cash & Cash Equivalents growth rates for Mega Lifesciences PCL have been 21% over the past three years , 22% over the past five years , and 9% over the past ten years .

Back to Top